ADIAL PHARMACEUTICALS INC's ticker is ADIL and the CUSIP is 00688A106. A total of 28 filers reported holding ADIAL PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $3,669 | -40.8% | 17,623 | -0.5% | 0.00% | – |
| Q1 2023 | $6,197 | -50.6% | 17,707 | -69.7% | 0.00% | – |
| Q4 2022 | $12,554 | -37.2% | 58,389 | 0.0% | 0.00% | – |
| Q3 2022 | $20,000 | -77.0% | 58,389 | +129.2% | 0.00% | – |
| Q1 2019 | $87,000 | +45.0% | 25,472 | +116.3% | 0.00% | – |
| Q4 2018 | $60,000 | – | 11,775 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VANGUARD GROUP INC | 282,909 | $424,000 | 0.00% |
| LADENBURG THALMANN FINANCIAL SERVICES INC. | 4,223 | $6,000 | 0.00% |
| VICTORY CAPITAL MANAGEMENT INC | 1,470 | $2,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 526 | $1,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 750 | $1,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 77,985 | $116,000 | 0.00% |
| MORGAN STANLEY | 535 | $1,000 | 0.00% |
| BROWN ADVISORY INC | 26,040 | $39,000 | 0.00% |
| BlackRock Inc. | 205,684 | $311,000 | 0.00% |